DrugPatentWatch Database Preview

Details for Patent: 9,931,305

Email this page to a colleague

« Back to Dashboard

Which drugs does patent 9,931,305 protect, and when does it expire?

Patent 9,931,305 protects SUBOXONE and KYNMOBI and is included in two NDAs.

This patent has one hundred and sixty-one patent family members in eighteen countries.

Summary for Patent: 9,931,305

Title:	Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
Abstract:	The present invention relates to rapid dissolve thin film drug delivery compositions for the oral administration of active components. The active components are provided as taste-masked or controlled-release coated particles uniformly distributed throughout the film composition. The compositions may be formed by wet casting methods, where the film is cast and controllably dried, or alternatively by an extrusion method.
Inventor(s):	Yang; Robert K. (Henderson, NV), Fuisz; Richard C. (Beverly Hills, CA), Myers; Garry L. (Kingsport, TN), Fuisz; Joseph M. (Surfside, FL)
Assignee:	MonoSol Rx, LLC (Warren, NJ)
Application Number:	15/438,458
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 9,931,305
Patent Claim Types: see list of patent claims	Use; Composition; Compound; Delivery; Dosage form;

Drugs Protected by US Patent 9,931,305

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Indivior Inc	SUBOXONE	buprenorphine hydrochloride; naloxone hydrochloride	FILM;BUCCAL, SUBLINGUAL	022410-001	Aug 30, 2010	AB	RX	Yes	No			Y
Indivior Inc	SUBOXONE	buprenorphine hydrochloride; naloxone hydrochloride	FILM;BUCCAL, SUBLINGUAL	022410-003	Aug 10, 2012	AB	RX	Yes	No			Y
Indivior Inc	SUBOXONE	buprenorphine hydrochloride; naloxone hydrochloride	FILM;BUCCAL, SUBLINGUAL	022410-002	Aug 30, 2010	AB	RX	Yes	No			Y
Indivior Inc	SUBOXONE	buprenorphine hydrochloride; naloxone hydrochloride	FILM;BUCCAL, SUBLINGUAL	022410-004	Aug 10, 2012	AB	RX	Yes	Yes			Y
Sunovion Pharms Inc	KYNMOBI	apomorphine hydrochloride	FILM;SUBLINGUAL	210875-001	May 21, 2020		RX	Yes	No			Y

International Family Members for US Patent 9,931,305

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	077803
Austria	536868
Austria	536869
Austria	553746
Australia	2002332118